Document:

Prepared by R.R. Donnelley Financial -- EX-4.13.1

 Exhibit 4.13.1 

SEPARATION AGREEMENT AND RELEASE 

THIS Separation Agreement and Release (this “Agreement”) is made by and between Matthew Lehman (the “Employee”), and Prima
Biomed Ltd., an Australian limited company (the “Company”). 
 WHEREAS, the Employee and the Company entered into an Employment
Agreement dated September 1, 2012 (the “Employment Agreement”) that sets forth the terms and conditions of the Employee’s employment with the Company, and 

WHEREAS, on July 9, 2014, the Employee and the Company have agreed to Early Termination of the Employment Agreement, such termination to
be effective August 10, 2014 (the “Termination Date”), 
 NOW, THEREFORE, the Employee and the Company each intending to be
legally held bound, hereby agree as follows: 
  

	 	1.	Consideration. In consideration for a release of claims and other promises and covenants set forth herein, the Company agrees to pay the Employee such consideration as is specified in
Section 4.1(a) of the Employment Agreement in accordance with the terms and conditions of the Employment Agreement, and such other consideration as the parties may expressly agree to in writing. Employee agrees to perform those duties as
set forth on the attached Schedule 1 through the Termination Date, and to sign and return to the Company a second release in the form attached hereto as Exhibit “A” on or within five (5) business days after the Termination Date.

  

	 	2.	Responsibilities through the Termination Date. Employee, as a condition of employment in good standing through the Termination Date, agrees to perform the reasonable duties as set forth by the incumbent CEO.

  

	 	3.	 Employee’s Release. Except for the payments and benefits as provided in this Agreement, the Employee on his own behalf and together with
his heirs, assigns, executors, agents and representatives hereby waives, releases and discharges the Company and its predecessors, successors (by merger or otherwise), parents, subsidiaries, affiliates and assigns, together with each and every of
their present, past and future officers, managers, directors, shareholders, members, general partners, limited partners, employees and agents and the heirs and executors of same (herein collectively referred to as the “Releasees”) from any
and all suits, causes of action, complaints, obligations, demands, common law or statutory claims of any kind, whether in law or in equity, direct or indirect, known or unknown (hereinafter “Claims”), which the Employee ever had or now has
against the Releasees, or any one of them occurring up to and including the date of the this Agreement. Notwithstanding anything herein to the contrary, the Employee’s release is not and shall not be construed as a release of any future claim
by the Employee against the Company, to the extent a claim may otherwise exist, for indemnity, contribution or cost of defense in connection with the Employee being made a party to a suit initiated by or on behalf of a third party, which suit is
based, in whole or in part, 

	 	
upon the work performed by the Employee for the Company within the scope of the Employee’s position and duties with the Company, or any alleged misconduct by the Employee within the scope of
the Employee’s former position and duties as an officer or employee of the Company. This release specifically includes, but is not limited to: 

  

	 	a.	any and all Claims for wages and benefits including, without limitation, salary, stock options, stock, royalties, license fees, health and welfare benefits, severance pay, vacation pay, and bonuses; 

 

	 	b.	any and all Claims for wrongful discharge, breach of contract, whether express or implied, violation of public policy, violation of any whistle-blower statutes, and Claims for breach of implied covenants of good faith
and fair dealing; 

  

	 	c.	any and all Claims for alleged employment discrimination, harassment or retaliation on the basis of race, color, religion, sex, age, national origin, veteran status, disability, and/or handicap, or any other protected
basis in violation of any federal, state or local statute, ordinance, judicial precedent or Executive order, including but not limited to any claims under the following statutes: Title VII of the Civil Rights Act of 1964, 42 U.S.C.
§2000e et seq.; the Civil Rights Act of 1866, 42 U.S.C. §1981; the Civil Rights Act of 1991; the Rehabilitation Act of 1972, as amended, 29 U.S.C. §701 et seq.; the Americans with Disabilities Act, 42 U.S.C. §12101 et
seq.; the Family and Medical Leave Act of 1993, 29 U.S.C. §2601, et seq.; the Fair Labor Standards Act, as amended, 29 U.S.C. §201, et seq.; the Fair Credit Reporting Act, as amended, 15 U.S.C. §1681, et seq.; and the
Employee Retirement Income Security Act of 1974, as amended, 29 U.S.C. §1000, et seq. (“ERISA”) or any comparable state statute, law or local ordinance, including without limitation the California Fair Employment and Housing
Act, the California Family Rights Act, the California Labor Code, and the California Business and Professions Code; 

  

	 	d.	any and all Claims under any federal or state statute relating to employee benefits or pensions; 

  

	 	e.	any and all Claims in tort or under common law, including but not limited to, any Claims for assault, battery, fraud, misrepresentation, defamation, interference with contract or prospective economic advantage,
intentional or negligent infliction of emotional distress, duress, loss of consortium, invasion of privacy and negligence; and 

  

	 	f.	any and all Claims for penalties, damages (including liquidated or punitive damages), interest, attorneys’ fees and costs. 

  

	 	4.	Acknowledgment. The Employee understands that the release of Claims contained in this Agreement extends to all of the aforementioned Claims and potential Claims which arose on or before the date of this
Agreement, whether now known or unknown, suspected or unsuspected, and that this constitutes an essential term of this Agreement. In connection with such waiver and release, Employee hereby expressly waives and relinquishes any and all claims,
rights or benefits that Employee has or may have under any state or federal statute that may otherwise limit the release of unknown claims, including but not limited to California Civil Code section 1542, which provides as follows:

 “A general release does not extend to claims which the creditor does not know or suspect to exist in his or her
favor at the time of executing the release, which if known by him or her must have materially affected his or her settlement with the debtor.” 

  

			
	Prima-Lehman Separation Agreement	  	Page 2 of 10

 The Employee further understands and acknowledges the significance and consequences of this
Agreement and of each specific release and waiver, and expressly consents that this Agreement shall be given full force and effect to each and all of its express terms and provisions, including those relating to unknown and uncompensated Claims, if
any, as well as those relating to any other Claims specified herein. The Employee hereby waives any right or Claim that the Employee may have to employment, reinstatement or re-employment with the Company. 

 

	 	5.	Remedies. All remedies at law or in equity shall be available to the Releasees for the enforcement of this Agreement. This Agreement may be pleaded as a full bar to the enforcement of any Claim that the
Employee may assert against the Releasees. 

  

	 	6.	No Admission. Neither the execution of this Agreement, nor the terms hereof, constitute an admission by the Company or by the Employee of any liability to the other party. 

 

	 	7.	Employment Agreement; Terms to Survive. For the avoidance of doubt, the Company and Employee acknowledge and confirm agreement to the following: 

 

	 	a.	Section 2.1 of the Employment Agreement regarding Confidentiality shall survive termination of the Employment Agreement. 

  

	 	b.	Section 2.2 of the Employment Agreement regarding Inventions shall survive termination of the Employment Agreement for three (3) years. 

 

	 	c.	As of the Termination Date, the Employee’s commitments regarding Noncompetition in Section 2.3 of the Employment Agreement shall end. 

 

	 	d.	Section 2.4 of the Employment Agreement regarding Non-solicitation shall survive termination of the Employment Agreement for six (6) months. 

 

	 	e.	 As specified in Section 4.6(d) of the Employment Agreement, the Employee agrees, for a period of three years (3) after the termination date of
Employee’s employment, and subject to any reasonable limitations posed by the terms and conditions of his then-current employment, to cooperate reasonably in regard to matters related to the Company where Employee’s availability
is requested by the Company on reasonable advance notice, including matters in which Employee acted on behalf of the Company and as to which his continued advice and cooperation are reasonably regarded as necessary in order to bring such
matters to a conclusion or to resolve a dispute relating thereto. Such assistance shall be scheduled at a mutually agreeable time and place in such a manner as not to 

  

			
	Prima-Lehman Separation Agreement	  	Page 3 of 10

	 	
interfere with any alternative employment obtained by Employee, and this provision shall not require Employee to take a leave of absence from, give up, or otherwise materially contravene or
detrimentally interfere with the terms and conditions of any subsequent employment he may have obtained or have a reasonable likelihood of obtaining. If such cooperation is requested at a time when Employee is no longer receiving severance payments
pursuant to Section 4.1(a) of the Employment Agreement, the Company shall pay reasonable compensation to Employee and in all cases shall pay all reasonable out of pocket expenses incurred by his in connection with such cooperation, including
but not limited to reasonable travel, hotel, meals, car rental and telephone expenses, as approved in advance by the Company. 

  

	 	f.	Section 5 of the Employment Agreement regarding Indemnification of Employee shall survive termination of the Employment Agreement for five (5) years. 

 

	 	8.	Entire Agreement. This Agreement and any attachments contains the entire agreement of the parties with respect to the subject matter hereof, and shall be binding upon their respective heirs, executors,
administrators, successors and assigns. In the event there is any inconsistency between the terms of this Agreement and the Employment Agreement, the terms of this Agreement shall control. 

 

	 	9.	Non-Disparagement. The parties mutually agree that they will not at any time defame, disparage or impugn the reputation of the other in any future communications with any third-party or entity. Employee will not
disparage the reputation of the Company or its products, services, business affairs or financial condition, or any of the Company’s directors, officers, employees, members, clients, agents or representatives. Company agrees to respond to any
employment or other inquires about Employee by only providing dates of employment, title or position held, and confirmation of salary if requested, and stating that it is Company policy not to release any additional information.
“Disparage,” as used in this Agreement, means to make any statement, written or oral, that casts another party in a negative light of any kind, or implies or attributes any negative quality to another party. However, neither this Paragraph
nor anything in this Agreement shall prohibit either party from making truthful statements to governmental agencies or authorities as may be required or permitted by applicable law or, with respect to the Company, to its owners, investors,
creditors, insurers, agents or professional representatives as necessary for legitimate business purposes. 

  

	 	10.	Severability. If any term or provision of this Agreement shall be held to be invalid or unenforceable for any reason, then such term or provision shall be ineffective to the extent of such invalidity or
unenforceability without invalidating the remaining terms or provisions hereof, and such term or provision shall be deemed modified to the extent necessary to make it enforceable. 

 

	 	11.	 Advice of Counsel; Revocation Period. The Employee is hereby advised to seek the advice of counsel prior to signing this Agreement. The
Employee hereby acknowledges that the Employee is acting of his own free will, that he has been afforded a reasonable time to read and review the terms of this Agreement, and that he is voluntarily entering into this Agreement with full knowledge of
its provisions and effects. The Employee 

  

			
	Prima-Lehman Separation Agreement	  	Page 4 of 10

	 	
further acknowledges that he has been given at least ten (10) days within which to consider this Agreement. This Agreement shall become effective on the date the Company receives the signed
agreement from the Employee (the “Effective Date”). 

  

	 	12.	Employee’s Representation. The Employee represents and warrants that he has not assigned any claim that he purports to release hereunder and that he has the full power and authority to enter into this
Agreement and bind each of the persons and entities that the Employee purports to bind. The Employee further represents and warrants that he is bound by, and agrees to remain bound by, his post-employment obligations set forth in the Employment
Agreement. 

  

	 	13.	Amendments. Neither this Agreement nor any term hereof may be changed, waived, discharged, or terminated, except by a written agreement signed by the parties hereto. 

 

	 	14.	Governing Authority. This Agreement shall be governed by and construed in accordance with the laws of the State of California, without regard to the principles of conflicts of laws of any jurisdiction. The
Employee agrees that the Company shall have the right to commence and maintain an action hereunder in the courts appropriate for the location at which the Company maintains its corporate offices, and the Employee hereby submits to the jurisdiction
and venue of such courts. 

  

	 	15.	Fees and Costs. The parties shall bear their own attorneys’ fees and costs in connection with the preparation and execution of this Agreement and in connection with any disputes arising under this
Agreement. 

  

	 	16.	Counterparts. This Agreement may be executed in counterparts and delivered via facsimile or other electronic means. 

  

	 	17.	Legally Binding. The terms of this Agreement contained herein are contractual, and not a mere recital. 

*    *    *    *    *    * 

  

			
	Prima-Lehman Separation Agreement	  	Page 5 of 10

 IN WITNESS WHEREOF, the Employee, acknowledging that he is acting of his own free will after
having had the opportunity to seek the advice of counsel and a reasonable period of time to consider the terms of this Agreement and the Company, have caused the execution of this Agreement as of this day and year written below. 

 

			
	For Prima Biomed Ltd
	Name:	 	Lucy Turnbull AO
	Title:	 	Chairman of the Board
		
	Signature:	 	 /s/ Lucy Turnbull 

		
	Date:	 	7/9/14
	
	For Matthew Lehman
		
	Signature:	 	 /s/ Matthew Lehman

		
	Date:	 	7/9/14

  

			
	Prima-Lehman Separation Agreement	  	Page 6 of 10

 Schedule 1 

To Separation Agreement and Release 

During the month of July and through the Termination Date, to affect a smooth transition, Employee agrees to complete the following with the
incumbent CEO, as well as other reasonable tasks as requested by the incumbent CEO: 
  

	 	a.	Business development debrief 

  

	 	i.	CVac collaboration discussions, outlicensing discussions 

  

	 	ii.	New potential opportunities that have been discussed 

  

	 	b.	Outline of competitive landscape in cancer immunotherapy and ovarian cancer 

  

	 	c.	Substantive advanced drafts of the Director’s Report and Review of Operations as necessary for the company Annual Report 

  

	 	d.	Consultation and advice on company vendors and consultants, as well as a review of contracts and budgetary considerations of ongoing clinical trials 

 

	 	e.	Assistance with communications to external stakeholders (shareholders, media, etc.) under the direction of the incumbent CEO 

  

	 	f.	Assistance with due diligence activities for ongoing potential transactions, as requested by the incumbent CEO 

  

	 	g.	Wind up operations in Redwood City. As directed by incumbent CEO, organize and transfer all documents and supplies from the Redwood City office to other Prima locations(s). Dispose of office and service leases and
equipment on terms as favorable as possible, and as directed by incumbent CEO. 

  

	 	h.	As directed by incumbent CEO, transfer signing authority on any company bank and credit accounts 

  

			
	Prima-Lehman Separation Agreement	  	Page 7 of 10

 EXHIBIT A 

General Release 
  

	 	1.	Employee’s Release. Pursuant to the Separation Agreement and Release entered into between Matthew Lehman (the “Employee”), and Prima Biomed Ltd., an Australian limited company (the
“Company”) dated July 9 2014,, (the “Agreement”), and except for the payments and benefits as provided in the Agreement, the Employee on his own behalf and together with his heirs, assigns, executors, agents and
representatives hereby waives, releases and discharges the Company and its predecessors, successors (by merger or otherwise), parents, subsidiaries, affiliates and assigns, together with each and every of their present, past and future officers,
managers, directors, shareholders, members, general partners, limited partners, employees and agents and the heirs and executors of same (herein collectively referred to as the “Releasees”) from any and all suits, causes of action,
complaints, obligations, demands, common law or statutory claims of any kind, whether in law or in equity, direct or indirect, known or unknown (hereinafter “Claims”), which the Employee ever had or now has against the Releasees, or any
one of them occurring up to and including the date of the this General Release (the “Release”). Notwithstanding anything herein to the contrary, the Employee’s release is not and shall not be construed as a release of any future claim
by the Employee against the Company, to the extent a claim may otherwise exist, for indemnity, contribution or cost of defense in connection with the Employee being made a party to a suit initiated by or on behalf of a third party, which suit is
based, in whole or in part, upon the work performed by the Employee for the Company within the scope of the Employee’s position and duties with the Company, or any alleged misconduct by the Employee within the scope of the Employee’s
former position and duties as an officer or employee of the Company. This release specifically includes, but is not limited to: 

  

	 	a.	any and all Claims for wages and benefits including, without limitation, salary, stock options, stock, royalties, license fees, health and welfare benefits, severance pay, vacation pay, and bonuses; 

 

	 	b.	any and all Claims for wrongful discharge, breach of contract, whether express or implied, violation of public policy, violation of any whistle-blower statutes, and Claims for breach of implied covenants of good faith
and fair dealing; 

  

	 	c.	 any and all Claims for alleged employment discrimination, harassment or retaliation on the basis of race, color, religion, sex, age, national origin,
veteran status, disability, or any other protected basis in violation of any federal, state or local statute, ordinance, judicial precedent or Executive order, including but not limited to any claims under the following statutes: Title VII of the
Civil Rights Act of 1964, 42 U.S.C. §2000e et seq.; the Civil Rights Act of 1866, 42 U.S.C. §1981; the Civil Rights Act of 1991; the Rehabilitation Act of 1972, as amended, 29 U.S.C. §701 et seq.; the Americans with
Disabilities Act, 42 U.S.C. §12101 et seq.; the Family and Medical Leave Act of 1993, 29 U.S.C. §2601, et seq.; the 

  

			
	Prima-Lehman Separation Agreement	  	Page 8 of 10

	 	
Fair Labor Standards Act, as amended, 29 U.S.C. §201, et seq.; the Fair Credit Reporting Act, as amended, 15 U.S.C. §1681, et seq.; and the Employee Retirement Income Security Act of
1974, as amended, 29 U.S.C. §1000, et seq. (“ERISA”) or any comparable state statute, law or local ordinance, including without limitation the California Fair Employment and Housing Act, the California Family Rights Act, the
California Labor Code, and the California Business and Professions Code; 

  

	 	d.	any and all Claims under any federal or state statute relating to employee benefits or pensions; 

  

	 	e.	any and all Claims in tort or under common law, including but not limited to, any Claims for assault, battery, fraud, misrepresentation, defamation, interference with contract or prospective economic advantage,
intentional or negligent infliction of emotional distress, duress, loss of consortium, invasion of privacy and negligence; and 

  

	 	f.	any and all Claims for penalties, damages (including liquidated or punitive damages), interest, attorneys’ fees and costs. 

  

	 	2.	Acknowledgment. The Employee understands that the release of Claims contained in this Release extends to all of the aforementioned Claims and potential Claims which arose on or before the date of this Release,
whether now known or unknown, suspected or unsuspected, and that this constitutes an essential term of this Release. In connection with such waiver and release, Employee hereby expressly waives and relinquishes any and all claims, rights or benefits
that Employee has or may have under any state or federal statute that may otherwise limit the release of unknown claims, including but not limited to California Civil Code section 1542, which provides as follows: 

“A general release does not extend to claims which the creditor does not know or suspect to exist in his or her favor at the time of
executing the release, which if known by him or her must have materially affected his or her settlement with the debtor.” 
 The
Employee further understands and acknowledges the significance and consequences of this Release and of each specific release and waiver, and expressly consents that this Release shall be given full force and effect to each and all of its express
terms and provisions, including those relating to unknown and uncompensated Claims, if any, as well as those relating to any other Claims specified herein. The Employee hereby waives any right or Claim that the Employee may have to employment,
reinstatement or re-employment with the Company. 
  

	 	3.	Payment of Final Wages. Employee represents and acknowledges that as of the Termination Date, Employee was paid for all wages earned through the Termination Date, including all accrued but unused vacation pay,
and that such payment was not conditioned on Employee signing this Release. 

  

			
	Prima-Lehman Separation Agreement	  	Page 9 of 10

	 	4.	Definitions. Capitalized terms used in this Release but not defined herein shall have the same meanings as set forth in the Agreement. This Release constitutes the “Second Release” as described in the
Agreement. 

  

	 	5.	Voluntary Assent. The Employee hereby acknowledges that the Employee is acting of his own free will, that he has been afforded a reasonable time to read and review the terms of this Release, and that he is
voluntarily entering into this Release with full knowledge of its provisions and effects, and that there has been no transfer or assignment of any of the Claims released in this Release. 

 

	
	 /s/    Mathew
Lehman        

	Mathew Lehman
	
	Dated: 9 July 2014

  

			
	Prima-Lehman Separation Agreement	  	Page 10 of 10Prepared by R.R. Donnelley Financial -- EX-4.15.1

 Exhibit 4.15.1 

Chief Executive Officer Employment Agreement 
 between

 Prima Biomed Ltd. 
 Lvl 7, 151 Macquarie St 

Sydney, NSW, 2145 
 Australia 

(hereinafter, known as the “Corporation” or the “Company” ) 

and 
 Mr. Marc Voigt 

(hereinafter, known as “Mr. Voigt”, “Employee” or “CEO”) 

(hereinafter, the “Corporation” or the “Company” and “Mr. Voigt”, “Employee” or “CEO” are together called
the “Parties” and each of them a “Party”) 
 Paragraph 1 

Duties and Responsibilities 
  

	1.	Mr. Voigt shall have the title and shall perform the responsibilities and duties of the Chief Executive Officer. Mr. Voigt shall perform all duties assigned to him in accordance with the terms of this
Agreement by the Company’s board of directors (“Board”) principally through its Chairman, faithfully, diligently and to the best of his ability. Such duties include, without limitation, the overseeing and implementation of the
business plan adopted by the Board (as may be revised from time to time by the Board). Mr. Voigt shall perform the services contemplated under this Agreement in accordance with the policies established by and under the direction of the Board.
Mr. Voigt shall have such corporate power and authority as shall reasonably be required to enable him to discharge his duties under this Agreement. In addition, the Company shall continue to nominate Mr Voigt, recommend to stockholders of the
Company the election of Mr Voigt, and use its other reasonable efforts to enable Mr Voigt to serve on the Board for the Employment Period. 

  

	2.	Mr. Voigt manages the business of the Company in its sector according to the legal provisions, the provisions of the partnership agreement and the decisions of the Company meeting or the Advisory Board.
Mr. Voigt attends shareholder meetings, unless otherwise regulated. Mr. Voigt represents the Company as long as otherwise provided, alone. 

	3.	Mr. Voigt will devote his energy and all his knowledge and experience to the Company and all of its subsidiaries. Mr. Voigt’s workplace is the home/base of Prima Biomed GmbH, a 100% subsidiary of the Company
in which Mr. Voigt is the executive/managing director, in Leipzig and primarily Berlin, Germany. Mr. Voigt agrees to business trips and to work abroad when required. 

Paragraph 2 
 Agreement 

 

	1.	Mr. Voigt was appointed on 9 July 2014 as Chief Executive Officer and Executive Director of the Company. 

  

	2.	This Agreement commences on 9th of July 2014 for a period of 3 years. Each Party agrees to give each other at least 6 months’ notice of its intention to extend
the term of this Agreement. 

  

	3.	Termination of this Agreement must be in writing. 

  

	4.	The right to terminate immediately for Cause remains unaffected. 

  

	5.	This Agreement ends with no further notice when either Mr. Voigt has reached retirement age or if he receives a pension due to disability. 

 

	6.	This Agreement ends with no further notice when the employment contract as managing director of Prima Biomed GmbH between Mr. Voigt and Prima Biomed GmbH, a 100% subsidiary of the Company, ends. 

 

	7.	The Company shall have the right at any time following the delivery of the notice of termination (for any reason) to relieve Mr. Voigt of his offices, duties and responsibilities and to place him on a leave of
absence status. 

  

	8.	Despite any provision of this Agreement, the Company is not required to pay or provide any amounts or benefits to Mr. Voigt which do not comply with the provisions of Part 2 D.2, Division 2 of the Corporations Act
2001 (Cth) without the need to obtain shareholder approval. To the extent that this Agreement requires the Company to pay or provide any such amounts or benefits, Mr. Voigt agrees and acknowledges that shareholder approval must first be
obtained and hereby irrevocably consents to forego those amounts or benefits if shareholder approval is not obtained. 

  

	9.	Upon the termination of Employee’s employment for any reason, he shall, upon request by the Company: 

  

	 	(a)	immediately resign without claim for compensation from all offices held in the Company and any subsidiary (with regard to the employment contract as managing director of Prima Biomed GmbH between the CEO and Prima
Biomed GmbH this clause is only applicable if the cause for termination of this Agreement is a cause according to § 626 BGB (German Civil Code)) or affiliate of the Company and membership in any organization and any office in any other company
acquired by reason of or in connection with Employee’s employment under this Agreement; Employee hereby irrevocably appoints the Company to be his attorney in his name and on his behalf to execute any documents and to do any things necessary or
requisite to give effect to this clause; 

	 	(b)	subject to the requirements to preserve any documents under applicable law or good clinical practices, deliver to the Company all documents (including, but not limited to, correspondence, lists of clients or customers,
plans, drawings, accounts, and other documents of whatsoever nature, and all copies thereof, whether on paper, computer memory or otherwise) made, compiled or acquired by Employee during his employment with the Company that relate to the business,
finances, or affairs of the Company or any subsidiary or affiliate of the Company, or its or their clients or customers and any other property of the Company or any subsidiary or affiliate of the Company which is in his possession, custody, care, or
control. Employee shall, if requested to do so by the Company, confirm in writing and under oath his compliance with his obligations under this clause; 

  

	 	(c)	irretrievably delete any information relating to the business of the Company or any subsidiary or affiliate of the Company stored on any magnetic or optical disc or memory and all matter derived therefrom which is in
his possession, custody, care, or control outside the premises of the Company and if requested to do so by the Company, confirm in writing and under oath his compliance with his obligations under this clause; and 

 

	 	(d)	for a period of three years (3) after the termination date of Employee’s employment, and subject to any reasonable limitations posed by the terms and conditions of his then-current employment, cooperate
reasonably in regard to matters related to the Company where Employee’s availability is requested by the Company on reasonable advance notice, including matters in which Employee acted on behalf of the Company and as to which his continued
advice and cooperation are reasonably regarded as necessary in order to bring such matters to a conclusion or to resolve a dispute relating thereto. Such assistance shall be scheduled at a mutually agreeable time and place in such a manner as not to
interfere with any alternative employment obtained by Employee, and this provision shall not require Employee to take a leave of absence from, give up, or otherwise materially contravene or detrimentally interfere with the terms and conditions of
any subsequent employment he may have obtained or have a reasonable likelihood of obtaining. If such cooperation is requested at a time when Employee is no longer receiving severance payments the Company shall pay reasonable compensation to Employee
and in all cases shall pay all reasonable out of pocket expenses incurred by his in connection with such cooperation, including but not limited to reasonable travel, hotel, meals, car rental and telephone expenses, as approved in advance by the
Company. In the event of legal proceedings this obligation shall continue for greater than 3 years. 

 Paragraph 3 

Compensation 
  

	1.	Mr. Voigt receives no fixed salary under this Agreement. 

	2.	As of 9 July 2014, Mr. Voigt will receive an annual gross salary of 195,000 Euro by Prima Biomed GmbH in fulfilment of the payment obligation of Prima Biomed GmbH under the employment contract as managing
director of Prima Biomed GmbH between Mr. Voigt and Prima Biomed GmbH which will be paid in monthly installments at the end of each month. Mr. Voigt may also get a cash performance bonus from Prima Biomed GmbH in the amount of up to 15,000
Euros. 

  

	3.	Mr. Voigt will be offered Short-Term and Long-Term Performance Incentive entitlements by the Company. The terms of his equity grants will be subject to approval of the shareholders of the Company.

  

	4.	Bonuses are voluntary on the part of the Company. Repeated payments do not constitute a legal claim. 

  

	5.	Travel cost incurred due to business trips will be reimbursed according to tax guidelines and company policies. 

Paragraph 4 
 Vacation 

Mr. Voigt is entitled to 30 days (working days) vacation based on a 5 Day Week. Vacation shall be (i) arranged in such way that the concerns of the
Company are not impaired and (ii) taken within the calendar year. Mr. Voigt has time until March of the following year to use his vacation days. Vacation is deemed approved if Prima Biomed GmbH approves the vacation under the employment
contract as managing director of Prima Biomed GmbH between Mr. Voigt and Prima Biomed GmbH. 
 Paragraph 5 

D & O Insurance 
 The Company must maintain adequate D&O
protection for Mr. Voigt in his capacity as CEO. The coverage must last for 5 years after Mr. Voigt leaves the Company. The adequacy of the coverage will depend on the business performance, which is continuously monitored and adjusted as
necessary. 
 Paragraph 6 
 Competition Clause 

 

	1.	The CEO is during the duration of the employment contract subject to a non-competition clause. He may not directly or indirectly, either independently, employed or otherwise, either on its own or on behalf of others
work for a company that is in business competition with the Company and / or its subsidiaries (e.g. same or similar technological approach) or that supports such a competition. 

 

	2.	In the same way the CEO is also prohibited during the period of such a ban to set up businesses, to acquire or thereto participate directly or indirectly in such businesses which are in competition to the Company.
Exempted from this prohibition are stakes in listed companies up to a level of 5.0% of the share capital. 

 Paragraph 8 

Post-contractual Competition Clause 
  

	1.	Mr Voigt undertakes for the duration of 24 months after this contract comes to an end not to work for a company on a freelance, dependent or other basis that is in direct or indirect competition with the Company or is
affiliated with a competitive company within the meaning of section 15 of the Stock Corporation Act (AktG). In the same way, the Mr Voigt shall be prohibited from forming, acquiring or directly or indirectly participating in such a company
during this term unless his shareholding does not enable him to exert influence over the governing bodies of the company in question. The post-contractual covenant not to compete shall also apply to the benefit of affiliates of the Company within
the meaning of section 15 of the Stock Corporation Act (AktG). The covenant not to compete shall cover the territory of Germany, Australia and the United States of America. 

 

	2.	The Company undertakes to pay the Mr Voigt for the duration of the post-contractual covenant not to compete compensation in the amount of 50% of the average numeration received by him over the last twelve months. The
compensation shall be payable at the end of each month. The Company may at any time waive the post-contractual covenant not to compete by observing a notice period of six months; in such event, the obligation of the Company to pay compensation shall
lapse. 

 Paragraph 9 
 Secrecy 

 

	1.	Mr. Voigt is obliged to keep all entrusted to him or he otherwise became known information about the Company secret from third parties. This information includes, in particular, the operating and business secrets,
internal, tax, financial and corporate relations of society, inventions, patents and know-how as well as the personal or financial circumstances of the employees of the Company and any of the other management members. In case of doubt, the Company
should be consulted. 

  

	2.	Mr. Voigt is also obligated to keep all information entrusted to him about the customers and business partners of the Company to third parties confidential. This information includes, in particular, the operating
and business secrets of customers and business partners, internal, fiscal, economic and social conditions of customers and business partners, the personal or financial circumstances of the employees of customers and business partners, as well as the
fact that a particular person customer or business partner of the company. In case of doubt, the Company should be consulted. 

  

	3.	The confidentiality obligations under items 1 and 2 shall not exist where legal statement obligations which or where Mr. Voigt was in individual cases released for certain facts in advance of the confidentiality
and if the disclosure in the financial interest of the Company and of an appropriate disclosure of the information society is not damage is done. 

  

	4.	All Mr. Voigt passed or otherwise associated traditional documents and items remain the property of the Company. Mr. Voigt has all documents and objects of the Company, which were entrusted to him or which
otherwise, were obtained, handed over immediately upon request of the Company. 

  

	5.	The obligations of this Paragraph 8 continue after termination of this employment Agreement without limitation. 

 Paragraph 10 

Records, Notes and Log 
 Upon leaving the Company or upon
termination of Mr. Voigt’s Agreement, Mr. Voigt is obligated to hand over all documents, correspondences, and all relevant matter to the Company. Mr. Voigt is not allowed to keep any documents, unless they pertain to him
personally. 
 Paragraph 11 
 Inventions 

 

	1.	Copyrights and other intellectual property rights, in particular rights to inventions or technical improvements that Mr. Voigt has made while working for the Company or due to its experience from his work for the
Company or as a result of work of the Company or due to work by the Company are owned by the Company exclusively. 

  

	2.	The CEO hereby assigns all corresponding rights to the Company. The Company accepts such assignment. The Company is not obliged to any additional compensation in this regard. 

Paragraph 12 
 Administration 

For purposes of this Agreement, Mr Voigt agrees that employment issues will be generally administered by the Company’s wholly owned subsidiary Prima
Biomed GmbH, located at Deutscher Platz 5E 04103 Leipzig, Germany. Mr Voigt, for purposes of tax, benefits, and employment law, is a resident of Germany. Notwithstanding the foregoing, nothing in this Agreement shall by understood to limit Mr
Voigt’s obligations and rights as an officer of the Company with duties and responsibilities to Company and all of its subsidiaries and affiliates worldwide. 

Paragraph 13 
 Miscellaneous provisions 

 

	1.	If any provision of this Agreement is invalid, the validity of the remaining provisions shall not be affected. The parties are obliged to replace the invalid determination by a valid provision, which reaches the goal
that the invalid provision is striving for as near as possible. 

  

	2.	Changes or additions to this Agreement must be made in writing. This also applies to the determination of the change in the provisions of the preceding sentence. 

 

	3.	This Agreement shall be governed by the laws of Australia. 

 Definitions 

Definition of Cause. For purposes of this Agreement, “Cause” shall mean the Employee has, during the Employment Period: 

 

	 	(a)	defaulted or breached any of the material provisions of this Agreement, or any material provision of an agreement with any other Company affiliate; 

 

	 	(b)	been indicted, arrested or convicted of, or plead guilty or no contest to, a felony or other crime, including crimes involving fraud, larceny, embezzlement, moral turpitude or dishonesty, or engaged in any act which is
a violation of any law or regulation protecting the rights of employees or relating to the conduct of the Company’s or any of its affiliates’ business; 

  

	 	(c)	intentionally committed any act, which materially detrimentally impacts on the business, business relationships or reputation of the Company, its affiliates, any employee or director of the Company or its affiliates,
and such act was undertaken without the authorization of the Board; 

  

	 	(d)	during the performance of Employee’s duties been habitually under the influence of alcohol or drugs and this materially impacted the business or reputation of the Company or its affiliates or the Employee’s
ability to conduct his duties under this Agreement; 

  

	 	(e)	failed to follow reasonable and lawful directives of the Board; 

  

	 	(f)	failed or refused to perform his principal duties and responsibilities as set forth in Section 1 hereof, if such failure or refusal is not cured within thirty (30) days after written notice thereof to Employee
by the Company; 

  

	 	(g)	committed an act, or failed to commit an act, involving the Company or its affiliates that amounts to willful misconduct, wanton misconduct or gross negligence, including without limitation any violation of the
Company’s or its affiliates’ anti-discrimination and anti-harassment policies; 

  

	 	(h)	intentionally engaged in any activity that is in conflict with or adverse to the interests of the Company or its affiliates, including without limitation violation of foreign or domestic anti-corruption laws, rules and
regulations; 

  

	 	(i)	breached Employee’s fiduciary duty to the Company or its affiliates (whether or not for personal profit); or 

  

	 	(j)	committed an act of self-dealing under violation of his rights and duties as CEO of the Company. 

					
	 1 August 2014
	 		 	 1 August 2014

	Date	 		 	Date
			
	 /s/ Marc Voigt
	 		 	 /s/ Lucy Turnbull

	Marc Voigt	 		 	Prima BioMed Ltd.
		 		 	Corporation, represented by its Chairman, Lucy Turnbull

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00235-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00235-of-00352.parquet"}]]